Potentiation by endothelin-1 of vasoconstrictor response in stroke-prone spontaneously hypertensive rats
Citation
Y. Matsumura et al., Potentiation by endothelin-1 of vasoconstrictor response in stroke-prone spontaneously hypertensive rats, EUR J PHARM, 415(1), 2001, pp. 45-49
Categorie Soggetti
Pharmacology & Toxicology
Journal title
EUROPEAN JOURNAL OF PHARMACOLOGY
SICI code
0014-2999(20010309)415:1<45:PBEOVR>2.0.ZU;2-M
Abstract
Norepinephrine-induced vasoconstriction was significantly greater in perfus
ed mesenteric arteries of stroke-prone spontaneously hypertensive rats (SHR
SPs) compared with cases of age-matched Wistar Kyoto rats (WKYs). Neither e
ndothelin ETA receptor antagonist FR139317 ((R)2-[(R)-2-[(S)-2-[[1-(hexahyd
ro-1 H-azepinyl)]carbonyl]amino-4-methyl-pentanoyl] amino-3-[3-(1-methyl-1
H-indoyl)]propionyl]amino-3-(2-pyridyl) propionic acid) nor endothelin ETB
receptor antagonist BQ788 [N-cis-2,6-dimethylpiperidinocarbonyl-L-methylleu
cyl-D-1-methoxycarbonyl-tryptophanyl-D-norleucine] affected the increased r
esponses observed in SHRSPs, suggesting that endogenous endothelin-1 is not
involved in this phenomenon. Norepinephrine-induced vasoconstriction was s
ignificantly enhanced by subpressor dose of endothelin-1 (0.3 nM). both in
SHRSPs and WKYs. Ln SHRSPs, endothelin-1-induced enhancement was abolished
by FR139317, in contrast to the case with WKYs, in which BQ788 markedly sup
pressed endothelin-1-induced augmentation of norepinephrine responses. Our
results indicate that exogenous endothelin-1 enhances contractile responses
to norepinephrine in mesenteric arteries of WKYs and SHRSPs, through activ
ation of different receptor subtypes. (C) 2001 Published by Elsevier Scienc
e B.V.